Esab CORP
Market Movers (8-K)
NYSE
ESAB
Esab CORPESAB Corporation appoints Mitchell P. Rales as Executive Chair and grants performance-based stock options to leadership.
NYSE
ESAB
Esab CORPESAB Corporation announced the completion of its acquisition of Eddyfi Technologies for $1.45 billion, financed through cash, senior notes, and preferred stock.
Capital raise
NYSE
ESAB
Esab CORPESAB Corporation announced the results of its 2026 Annual Meeting of Stockholders, including the election of nine directors and the ratification of its independent auditor.
NYSE
ESAB
Esab CORPESAB Corporation reported record first quarter 2026 sales of $746 million, a 10% increase year-over-year, driven by acquisitions, while core organic sales decreased by 1%.
Capital raise
NYSE
ESAB
Esab CORPESAB Corporation announced the appointment of R. Brent Jones as its new Chief Financial Officer, effective early May 2026, while also reaffirming its 2026 financial outlook.
NYSE
ESAB
Esab CORPESAB Corporation issued $1 billion in 5.625% senior notes due 2031 to partially fund the $1.45 billion acquisition of Eddyfi Technologies.
Delay expected
Capital raise
Quarterly Earnings (10-Q)
NYSE
ESAB
Esab CORPESAB Corporation reported a 9.9% increase in net sales for Q1 2026, driven by acquisitions and favorable foreign exchange, though net income from continuing operations declined due to increased expenses and acquisition-related charges.
Capital raise
Worse than expected
NYSE
ESAB
Esab CORPESAB Corporation reports increased net sales and Adjusted EBITDA for Q3 2025, driven by strategic acquisitions, but net income and EPS declined due to higher interest expenses and discontinued operations.
Delay expected
Worse than expected
Capital raise
NYSE
ESAB
Esab CORPESAB Corporation reports mixed second-quarter results with sales growth driven by acquisitions, but a decline in net income and organic sales.
Delay expected
Worse than expected
Capital raise
NYSE
ESAB
Esab CORPESAB Corporation's first quarter 2025 results show a slight decrease in net sales but an increase in Adjusted EBITDA compared to the same period last year.
NYSE
ESAB
Esab CORP10-Q: ESAB Corporation Reports Mixed Q3 Results Amidst Currency Headwinds and Strategic Acquisitions
ESAB Corporation's third-quarter results show a slight decrease in net sales, but improved profitability driven by pricing and cost management, alongside strategic acquisitions.
Better than expected
NYSE
ESAB
Esab CORPESAB Corporation's second-quarter results show increased profitability driven by lower costs and favorable product mix, despite a slight decrease in net sales.
Better than expected
Annual Reports (10-K)
NYSE
ESAB
Esab CORPESAB Corporation reports increased net sales driven by acquisitions, but faces declining organic sales, lower net income, and increased debt in its 2025 annual filing.
Worse than expected
Capital raise
NYSE
ESAB
Esab CORPESAB Corporation's FY2024 results reveal a slight revenue decrease, influenced by strategic acquisitions and unfavorable foreign currency translation, while Adjusted EBITDA and Core adjusted EBITDA margins improve.
Worse than expected
NYSE
ESAB
Esab CORPESAB Corporation's 10-K filing details an executive promotion, compensation plans, and a comprehensive list of its subsidiaries.
Insider Trading (Form 4)
NYSE
ESAB
Esab CORPRanjana N Bhagwakar, EVP, Business Operations of ESAB Corp, received 15,777 shares of common stock on July 15, 2026.
NYSE
ESAB
Esab CORPESAB Corp executive Ranjana N. Bhagwakar reports acquisition of restricted stock units and stock options.
NYSE
ESAB
Esab CORPESAB Corp director Robert S. Lutz reported the acquisition of deferred stock units, representing a contingent right to receive shares of common stock.
NYSE
ESAB
Esab CORPDidier Teirlinck, a Director at ESAB Corp, acquired 134 deferred stock units on June 30, 2026, as a substitute for his director's cash retainer.
NYSE
ESAB
Esab CORPESAB Corp CEO Shyam Kambeyanda was granted performance-based stock options for 580,552 shares of common stock.
NYSE
ESAB
Esab CORPESAB Corp Chief Human Resources Officer Michele Campion was granted 52,250 performance-based stock options.
Proxy Statements (Def-14A)
NYSE
ESAB
Esab CORPESAB Corporation announces its 2026 Annual Meeting of Stockholders, outlining director elections, executive compensation, and corporate governance updates, including a significant capital raise and no cash bonuses for executives in 2025.
Worse than expected
Capital raise
NYSE
ESAB
Esab CORPESAB Corporation issues a supplement to its proxy statement clarifying the voting standard for the upcoming 2025 Annual Meeting of Stockholders.
NYSE
ESAB
Esab CORPESAB Corporation's 2025 Annual Meeting of Stockholders will be held virtually on May 8, 2025, with proxy materials available online.
NYSE
ESAB
Esab CORPESAB Corporation has released its proxy statement outlining proposals for the 2025 Annual Meeting of Stockholders, including director elections, auditor ratification, executive compensation approval, and an incentive plan amendment.
Better than expected
NYSE
ESAB
Esab CORPESAB Corporation's 2024 Annual Meeting of Stockholders will be held virtually on May 9, 2024, with proxy materials available online.
NYSE
ESAB
Esab CORPDEF 14A: ESAB Corp Seeks Stockholder Approval for Executive Pay and Director Elections at 2024 Annual Meeting
ESAB Corporation's proxy statement outlines proposals for the upcoming annual meeting, including director elections, ratification of the accounting firm, and an advisory vote on executive compensation.
Better than expected
Schedule 13D - Activist Investments
NYSE
ESAB
Esab CORPMitchell P. Rales has increased his beneficial ownership in ESAB Corporation to 7.1% through the acquisition of Series A Mandatory Convertible Preferred Stock and additional common stock contributions.
Capital raise
NYSE
ESAB
Esab CORPMitchell P. Rales, a significant beneficial owner, has committed $100 million to ESAB Corporation's new mandatory convertible preferred stock to fund a strategic acquisition.
Capital raise
Schedule 13G - Passive Investments
NYSE
ESAB
Esab CORPVanguard Capital Management has disclosed a beneficial ownership of 5.01% in Esab Corp, holding over 3 million shares.
NYSE
ESAB
Esab CORPT. Rowe Price Associates, Inc. has reported beneficial ownership of 10.9% of ESAB Corp's common stock as of March 31, 2026.
NYSE
ESAB
Esab CORPThe Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Esab Corp following an internal realignment that disaggregated reporting responsibilities.
NYSE
ESAB
Esab CORPT. Rowe Price Associates, Inc. has disclosed a 9.6% beneficial ownership stake in ESAB Corp, holding over 5.8 million shares of common stock.
NYSE
ESAB
Esab CORPSCHEDULE 13G/A: T. Rowe Price Boosts ESAB Corp Stake to 8.6%
T. Rowe Price Associates, Inc. has reported an 8.6% beneficial ownership stake in ESAB Corp common stock as of September 30, 2025.
NYSE
ESAB
Esab CORPT. Rowe Price Associates, Inc. has reported an 11.0% beneficial ownership stake in ESAB Corp's common stock, as detailed in an amended Schedule 13G filing.